ABBOTT LABORATORIES (ABL.DE) Fundamental Analysis & Valuation

FRA:ABL • US0028241000

Current stock price

87.72 EUR
-0.74 (-0.84%)
Last:

This ABL.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. ABL.DE Profitability Analysis

1.1 Basic Checks

  • In the past year ABL was profitable.
  • In the past year ABL had a positive cash flow from operations.
  • Each year in the past 5 years ABL has been profitable.
  • Each year in the past 5 years ABL had a positive operating cash flow.
ABL.DE Yearly Net Income VS EBIT VS OCF VS FCFABL.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

1.2 Ratios

  • With an excellent Return On Assets value of 7.52%, ABL belongs to the best of the industry, outperforming 82.54% of the companies in the same industry.
  • ABL's Return On Equity of 12.51% is fine compared to the rest of the industry. ABL outperforms 77.78% of its industry peers.
  • ABL's Return On Invested Capital of 9.17% is fine compared to the rest of the industry. ABL outperforms 74.60% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for ABL is in line with the industry average of 10.21%.
  • The last Return On Invested Capital (9.17%) for ABL is above the 3 year average (8.63%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 7.52%
ROE 12.51%
ROIC 9.17%
ROA(3y)10.6%
ROA(5y)10.1%
ROE(3y)18.49%
ROE(5y)18.82%
ROIC(3y)8.63%
ROIC(5y)9.58%
ABL.DE Yearly ROA, ROE, ROICABL.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

1.3 Margins

  • ABL has a Profit Margin of 14.72%. This is amongst the best in the industry. ABL outperforms 84.13% of its industry peers.
  • In the last couple of years the Profit Margin of ABL has grown nicely.
  • ABL has a Operating Margin of 18.85%. This is in the better half of the industry: ABL outperforms 76.19% of its industry peers.
  • In the last couple of years the Operating Margin of ABL has grown nicely.
  • ABL has a Gross Margin (56.68%) which is in line with its industry peers.
  • ABL's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 18.85%
PM (TTM) 14.72%
GM 56.68%
OM growth 3Y-1.98%
OM growth 5Y3.67%
PM growth 3Y-2.51%
PM growth 5Y2.53%
GM growth 3Y0.22%
GM growth 5Y-0.03%
ABL.DE Yearly Profit, Operating, Gross MarginsABL.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. ABL.DE Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ABL is still creating some value.
  • Compared to 1 year ago, ABL has more shares outstanding
  • ABL has less shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, ABL has an improved debt to assets ratio.
ABL.DE Yearly Shares OutstandingABL.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B
ABL.DE Yearly Total Debt VS Total AssetsABL.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B

2.2 Solvency

  • ABL has an Altman-Z score of 4.89. This indicates that ABL is financially healthy and has little risk of bankruptcy at the moment.
  • ABL's Altman-Z score of 4.89 is amongst the best of the industry. ABL outperforms 82.54% of its industry peers.
  • ABL has a debt to FCF ratio of 1.75. This is a very positive value and a sign of high solvency as it would only need 1.75 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 1.75, ABL belongs to the top of the industry, outperforming 80.95% of the companies in the same industry.
  • ABL has a Debt/Equity ratio of 0.19. This is a healthy value indicating a solid balance between debt and equity.
  • With a decent Debt to Equity ratio value of 0.19, ABL is doing good in the industry, outperforming 71.43% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 1.75
Altman-Z 4.89
ROIC/WACC1.08
WACC8.46%
ABL.DE Yearly LT Debt VS Equity VS FCFABL.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B 50B

2.3 Liquidity

  • A Current Ratio of 1.58 indicates that ABL should not have too much problems paying its short term obligations.
  • ABL has a Current ratio of 1.58. This is comparable to the rest of the industry: ABL outperforms 47.62% of its industry peers.
  • ABL has a Quick Ratio of 1.18. This is a normal value and indicates that ABL is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of ABL (1.18) is comparable to the rest of the industry.
  • The current and quick ratio evaluation for ABL is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.58
Quick Ratio 1.18
ABL.DE Yearly Current Assets VS Current LiabilitesABL.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B 25B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. ABL.DE Growth Analysis

3.1 Past

  • ABL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 10.28%, which is quite good.
  • Measured over the past 5 years, ABL shows a small growth in Earnings Per Share. The EPS has been growing by 7.13% on average per year.
  • Looking at the last year, ABL shows a small growth in Revenue. The Revenue has grown by 5.67% in the last year.
  • Measured over the past years, ABL shows a small growth in Revenue. The Revenue has been growing by 5.08% on average per year.
EPS 1Y (TTM)10.28%
EPS 3Y-1.2%
EPS 5Y7.13%
EPS Q2Q%11.94%
Revenue 1Y (TTM)5.67%
Revenue growth 3Y0.51%
Revenue growth 5Y5.08%
Sales Q2Q%4.42%

3.2 Future

  • The Earnings Per Share is expected to grow by 10.38% on average over the next years. This is quite good.
  • ABL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.06% yearly.
EPS Next Y11.53%
EPS Next 2Y10.76%
EPS Next 3Y10.34%
EPS Next 5Y10.38%
Revenue Next Year8.15%
Revenue Next 2Y8%
Revenue Next 3Y7.61%
Revenue Next 5Y7.06%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ABL.DE Yearly Revenue VS EstimatesABL.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20B 40B 60B
ABL.DE Yearly EPS VS EstimatesABL.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

4

4. ABL.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 19.94, ABL is valued on the expensive side.
  • Based on the Price/Earnings ratio, ABL is valued a bit cheaper than the industry average as 73.02% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Earnings ratio of 26.91, ABL is valued a bit cheaper.
  • Based on the Price/Forward Earnings ratio of 17.88, the valuation of ABL can be described as rather expensive.
  • ABL's Price/Forward Earnings is on the same level as the industry average.
  • The average S&P500 Price/Forward Earnings ratio is at 23.68. ABL is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 19.94
Fwd PE 17.88
ABL.DE Price Earnings VS Forward Price EarningsABL.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • ABL's Enterprise Value to EBITDA ratio is in line with the industry average.
  • Based on the Price/Free Cash Flow ratio, ABL is valued a bit cheaper than 66.67% of the companies in the same industry.
Industry RankSector Rank
P/FCF 24.13
EV/EBITDA 16
ABL.DE Per share dataABL.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

  • ABL's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The excellent profitability rating of ABL may justify a higher PE ratio.
PEG (NY)1.73
PEG (5Y)2.8
EPS Next 2Y10.76%
EPS Next 3Y10.34%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. ABL.DE Dividend Analysis

5.1 Amount

  • ABL has a Yearly Dividend Yield of 2.42%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 1.20, ABL pays a bit more dividend than its industry peers.
  • ABL's Dividend Yield is a higher than the S&P500 average which is at 1.89.
Industry RankSector Rank
Dividend Yield 2.42%

5.2 History

  • On average, the dividend of ABL grows each year by 10.37%, which is quite nice.
Dividend Growth(5Y)10.37%
Div Incr Years7
Div Non Decr Years7
ABL.DE Yearly Dividends per shareABL.DE Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

5.3 Sustainability

  • ABL pays out 63.09% of its income as dividend. This is not a sustainable payout ratio.
  • The dividend of ABL is growing around the same rate as the earnings are growing. If this keeps up the dividend growth is sustainable.
DP63.09%
EPS Next 2Y10.76%
EPS Next 3Y10.34%
ABL.DE Yearly Income VS Free CF VS DividendABL.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B
ABL.DE Dividend Payout.ABL.DE Dividend Payout, showing the Payout Ratio.ABL.DE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

ABL.DE Fundamentals: All Metrics, Ratios and Statistics

ABBOTT LABORATORIES

FRA:ABL (4/9/2026, 5:28:15 PM)

87.72

-0.74 (-0.84%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)01-22
Earnings (Next)04-14
Inst Owners81.83%
Inst Owner ChangeN/A
Ins Owners0.47%
Ins Owner ChangeN/A
Market Cap152.43B
Revenue(TTM)44.33B
Net Income(TTM)6.52B
Analysts80.57
Price Target114.26 (30.26%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.42%
Yearly Dividend2.06
Dividend Growth(5Y)10.37%
DP63.09%
Div Incr Years7
Div Non Decr Years7
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-0.9%
Min EPS beat(2)-1.06%
Max EPS beat(2)-0.75%
EPS beat(4)1
Avg EPS beat(4)-0.41%
Min EPS beat(4)-1.06%
Max EPS beat(4)0.73%
EPS beat(8)3
Avg EPS beat(8)0.09%
EPS beat(12)6
Avg EPS beat(12)0.64%
EPS beat(16)10
Avg EPS beat(16)5.12%
Revenue beat(2)0
Avg Revenue beat(2)-2.58%
Min Revenue beat(2)-3.88%
Max Revenue beat(2)-1.29%
Revenue beat(4)0
Avg Revenue beat(4)-1.72%
Min Revenue beat(4)-3.88%
Max Revenue beat(4)-0.33%
Revenue beat(8)0
Avg Revenue beat(8)-1.18%
Revenue beat(12)3
Avg Revenue beat(12)-0.45%
Revenue beat(16)7
Avg Revenue beat(16)1.23%
PT rev (1m)0%
PT rev (3m)-8.26%
EPS NQ rev (1m)-0.17%
EPS NQ rev (3m)-4.49%
EPS NY rev (1m)0%
EPS NY rev (3m)0.19%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.98%
Revenue NY rev (1m)1.08%
Revenue NY rev (3m)0.18%
Valuation
Industry RankSector Rank
PE 19.94
Fwd PE 17.88
P/S 4.03
P/FCF 24.13
P/OCF 18.65
P/B 3.42
P/tB 7.91
EV/EBITDA 16
EPS(TTM)4.4
EY5.02%
EPS(NY)4.91
Fwd EY5.59%
FCF(TTM)3.64
FCFY4.14%
OCF(TTM)4.7
OCFY5.36%
SpS21.79
BVpS25.63
TBVpS11.1
PEG (NY)1.73
PEG (5Y)2.8
Graham Number50.37
Profitability
Industry RankSector Rank
ROA 7.52%
ROE 12.51%
ROCE 11.9%
ROIC 9.17%
ROICexc 10.51%
ROICexgc 20.3%
OM 18.85%
PM (TTM) 14.72%
GM 56.68%
FCFM 16.68%
ROA(3y)10.6%
ROA(5y)10.1%
ROE(3y)18.49%
ROE(5y)18.82%
ROIC(3y)8.63%
ROIC(5y)9.58%
ROICexc(3y)9.83%
ROICexc(5y)11.21%
ROICexgc(3y)21.64%
ROICexgc(5y)29.96%
ROCE(3y)11.19%
ROCE(5y)12.44%
ROICexgc growth 3Y-22.35%
ROICexgc growth 5Y-6%
ROICexc growth 3Y-8.69%
ROICexc growth 5Y6.09%
OM growth 3Y-1.98%
OM growth 5Y3.67%
PM growth 3Y-2.51%
PM growth 5Y2.53%
GM growth 3Y0.22%
GM growth 5Y-0.03%
F-Score6
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 1.75
Debt/EBITDA 0.86
Cap/Depr 69.67%
Cap/Sales 4.9%
Interest Coverage 15.33
Cash Conversion 83.39%
Profit Quality 113.35%
Current Ratio 1.58
Quick Ratio 1.18
Altman-Z 4.89
F-Score6
WACC8.46%
ROIC/WACC1.08
Cap/Depr(3y)68.72%
Cap/Depr(5y)62.77%
Cap/Sales(3y)5.22%
Cap/Sales(5y)4.82%
Profit Quality(3y)83.05%
Profit Quality(5y)96.8%
High Growth Momentum
Growth
EPS 1Y (TTM)10.28%
EPS 3Y-1.2%
EPS 5Y7.13%
EPS Q2Q%11.94%
EPS Next Y11.53%
EPS Next 2Y10.76%
EPS Next 3Y10.34%
EPS Next 5Y10.38%
Revenue 1Y (TTM)5.67%
Revenue growth 3Y0.51%
Revenue growth 5Y5.08%
Sales Q2Q%4.42%
Revenue Next Year8.15%
Revenue Next 2Y8%
Revenue Next 3Y7.61%
Revenue Next 5Y7.06%
EBIT growth 1Y18.75%
EBIT growth 3Y-1.48%
EBIT growth 5Y8.93%
EBIT Next Year25.72%
EBIT Next 3Y14.17%
EBIT Next 5Y13.17%
FCF growth 1Y16.44%
FCF growth 3Y-1.78%
FCF growth 5Y5.26%
OCF growth 1Y11.78%
OCF growth 3Y-0.05%
OCF growth 5Y3.9%

ABBOTT LABORATORIES / ABL.DE Fundamental Analysis FAQ

What is the fundamental rating for ABL stock?

ChartMill assigns a fundamental rating of 7 / 10 to ABL.DE.


Can you provide the valuation status for ABBOTT LABORATORIES?

ChartMill assigns a valuation rating of 4 / 10 to ABBOTT LABORATORIES (ABL.DE). This can be considered as Fairly Valued.


How profitable is ABBOTT LABORATORIES (ABL.DE) stock?

ABBOTT LABORATORIES (ABL.DE) has a profitability rating of 8 / 10.


What is the financial health of ABBOTT LABORATORIES (ABL.DE) stock?

The financial health rating of ABBOTT LABORATORIES (ABL.DE) is 8 / 10.


Is the dividend of ABBOTT LABORATORIES sustainable?

The dividend rating of ABBOTT LABORATORIES (ABL.DE) is 5 / 10 and the dividend payout ratio is 63.09%.